Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Buy
2,148
+27
+1% +$4.89K 0.06% 113
2026
Q1
$312K Buy
2,121
+105
+5% +$17.1K 0.06% 108
2025
Q4
$393K Sell
2,016
-270
-12% -$64.3K 0.07% 101
2025
Q3
$654K Buy
2,286
+275
+14% +$70K 0.12% 82
2025
Q2
$440K Hold
2,011
0.08% 95
2025
Q1
$256K Sell
2,011
-6
-0.3% -$977 0.05% 108
2024
Q4
$336K Hold
2,017
0.07% 93
2024
Q3
$344K Sell
2,017
-37
-2% -$5.36K 0.07% 90
2024
Q2
$290K Buy
2,054
+55
+3% +$6.83K 0.06% 92
2024
Q1
$251K Hold
1,999
0.06% 102
2023
Q4
$211K Sell
1,999
-75
-4% -$8.19K 0.05% 106
2023
Q3
$220K Buy
2,074
+75
+4% +$8.68K 0.06% 99
2023
Q2
$238K Buy
+1,999
New +$207K 0.06% 97

Other funds holding ORCL

Lincoln Capital's ORCL Position: Q2 2026 in Review

Lincoln Capital increased its Oracle (ORCL) stake by 1.3% in Q2 2026, buying an estimated $4.89K and bringing the position to 2,148 shares worth $315K. The position accounts for 0.06% of the portfolio, ranked #113.

Lincoln Capital first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. The position peaked at $654K in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Lincoln Capital held 2,148 shares of Oracle worth $315K as of Q2 2026.
  • Lincoln Capital bought 27 Oracle shares in Q2 2026, an estimated $4.89K.
  • Oracle made up 0.06% of Lincoln Capital's portfolio in Q2 2026, its #113 holding.
  • Lincoln Capital first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • Lincoln Capital's Oracle position peaked at $654K in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.